Multiple Myeloma Medications
Definition of Multiple Myeloma: Multiple myeloma is a cancer of the plasma cells in bone marrow.
Drugs (by generic name) associated with Multiple Myeloma
The following drugs and medications are in some way related to, or used in the treatment of Multiple Myeloma. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
| Drug Name |
Reviews | Ratings |
||
|---|---|---|---|---|
| melphalan systemic (Pro, More...) | 0 review(s) | Rate It! | 4.0 | |
| bortezomib systemic (Pro, More...) | 1 review(s) | Not rated - Be the first | ||
| thalidomide systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| vincristine systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| lenalidomide systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| doxorubicin systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| carmustine systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| cyclophosphamide systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| doxorubicin liposomal systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
See also...
Latest Multiple Myeloma Blog Post
CytRx's Tamibarotene Demonstrates Statistically Significant Anti-Tumor Activity in Animal Trial for Multiple Myeloma
Data Broadens Tamibarotene's Potential Therapeutic Indications beyond APL
LOS ANGELES--(BUSINESS WIRE)--Jun 17, 2009 - CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company engaged in the development of high-value human...
View all Multiple Myeloma blog posts.
Multiple Myeloma Support Group Questions
Ask a Question about Multiple Myeloma:
Learn more about Multiple Myeloma
Medical encyclopedia results for:
